EDDA Technology Introduces IQQA®-Liver Suite To Provide Dedicated Total Solutions for Liver Cancer Diagnosis and Treatment Management

PRINCETON, N.J., Nov. 23, 2010 /PRNewswire/ -- EDDA Technology announced today that it will introduce its innovative IQQA®-Liver Suite, which provides dedicated total solutions for liver cancer diagnosis and operative treatment management, at the 96th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA). For better healthcare and patient management, the IQQA®-Liver Suite aims to enhance efficiency and precision in liver disease diagnosis, pre-operative treatment planning, intra-operative guidance, post-surgical assessment and follow-up.

The IQQA®-Liver Suite addresses the challenges of modern multidisciplinary advanced quantitative imaging evaluation and management, which often require the sharing of processing/analysis result in a real-time interactive/conferencing fashion, simultaneously and collaboratively from multiple departments in different locations. The IQQA®-Liver Suite utilizes EDDA's proprietary IT technology to streamline system platform architectural and workflow design. It not only offers immediate integration with hospitals' existing PACS systems, but also allows access to the 4-D IQQA®-Liver application for volumetric quantitative assessment and virtual operative simulations from anywhere anytime via the IQQA® On Demand Internet platform.  Furthermore, a virtual session may be created to allow simultaneous accesses to and manipulations of the same dataset, where conferencing/collaboration from multiple department/locations becomes easy to manage.

At the core of the suite, IQQA®-Liver, an advanced 4-D image quantitative evaluation system, is currently used by radiologists and surgeons worldwide in liver surgery, transplantation and interventional centers. The number of clinical image cases evaluated for pre- and post- operative assessment using IQQA®-Liver in hospitals has exceeded 1000 examinations, since the first commercial system installation in Q2 2009.  This innovative toolset assists physicians to perform fast real-time interactive assessment and volumetric quantification of liver, liver lobes, hepatics lesions and vessels from liver imaging data, as well as virtual simulation of resection, lobular/vascular manipulation and quantification to achieve desired treatment planning. In many instances, the use of quantitative IQQA®-Liver helps to facilitate the planning of precision treatment procedures on very challenging cases.

Using an individualized 3D E-Liver map generated by IQQA®-Liver, IQQA®-Guide (works-in-progress) of this suite further provides a real-time quantitative 3D navigation guide to assist physicians during interventional and surgical procedures. The system also provides quantitative risk analysis as well as territory/vascular analysis with quantified volumetry on targeted regions of interest during the guidance process.  The intra-operative IQQA®-Guide organically links the pre-surgical planning and post surgical assessment together to help physicians optimize the liver tumor management process.

EDDA Technology will be exhibiting other IQQA® Family of Products in Booth #8950 at the RSNA 2010, including IQQA®-Chest Enterprise CAD (Computer Aided Detection) for assisting physician's detection of small lung nodules from digital chest X-ray, and IQQA® –TomoS CAD (works-in-progress) for Digital X-ray Tomosynthesis. The first prospective study on chest X-ray CAD published in journal (Academic Radiology Vol. 15:5) demonstrated a significant sensitivity increase of physician's nodule detection from 63.8% without IQQA®-Chest to 92.7% with IQQA®-Chest assistance (while specificity kept high at 96.2% from the previous 98.1%).  

About EDDA Technology

EDDA Technology, Inc. is an innovative clinical computer solution provider in healthcare imaging and analysis. EDDA offers a series of next generation computer assistance solutions to the entire patient care management cycle, including enabling early detection and diagnosis of diseases, as well as enhancing efficiency and precision in treatment planning, management and follow-up. EDDA's goal is to deliver, with broad accessibility, advanced information analysis technologies that improve clinical workflow and accuracy. A privately held Delaware corporation, EDDA is headquartered in Princeton, New Jersey, and has a subsidiary in Shanghai, China. IQQA® is a registered trademark of EDDA Technology. www.eddatech.com

SOURCE EDDA Technology, Inc.